Remel, Inc. is recalling 2,819 units of its Yeastone Broth (11ML, 10/BOX) due to a defect that may report incorrect antifungal susceptibility test (AST) results during quality control. While there are no reported injuries, this issue could lead to a delayed medical response or the need for a patient to switch to a different antifungal treatment if the incorrect lab results are used. This product was distributed worldwide to laboratories and healthcare facilities.
The broth may produce inaccurate results when testing how effective antifungal drugs are against yeast. If a laboratory ignores these quality control failures, it could lead to improper patient treatment or delays in providing effective antifungal therapy.
Products may report incorrect AST results during quality control.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.